Antengene granted IND approval in China for ATG-201 in autoimmune disease
FDA grants rare paediatric disease designation to RedHill's opaganib
GSK to acquire Nuvalent for USD10.6bn to expand lung cancer portfolio
Argo Biopharma to present updated BW-20805 Phase II results at EAACI 2026 Congress
Curasight reports encouraging preliminary Phase 1 data for uTREAT in glioblastoma
Sanofi secures EU approval for subcutaneous Sarclisa with on-body injector
Sciwind Biosciences reports positive study data on ecnoglutide versus semaglutide
OriCell's GPC3 CAR-T Phase II hepatocellular carcinoma trial receives Chinese regulatory clearance
Owkin to build AI agents as part of K Pro collaboration with Sanofi
Gilead and Lakefront complete Ouro Medicines acquisition to expand autoimmune disease pipeline
Kexing Biopharm begins enrolment for Phase I trial of GB10 in China
Lupeng Pharmaceutical's rocbrutinib receives Chinese approval to treat R/R mantle cell lymphoma
Pharming secures FDA acceptance of Joenja filing for children with APDS